Bitget App
Trade smarter
Nasdaq-listed Anixa Biosciences board approves purchase of Bitcoin as reserve asset
Show original
Golden Finance reported that the board of directors of Nasdaq-listed Anixa Biosciences has approved the purchase of Bitcoin as a reserve asset. The company also reiterated its ongoing stock repurchase plan. The company's CEO Amit Kumar said that the decision on Bitcoin is another way of prudent financial management to achieve higher shareholder value. It is reported that Anixa Biosciences is a biotechnology company focused on the treatment and prevention of cancer.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$106,210.97
+1.34%
Ethereum
ETH
$3,576.47
-0.08%
Tether USDt
USDT
$0.9998
-0.01%
XRP
XRP
$2.53
+7.19%
BNB
BNB
$994.39
-0.35%
Solana
SOL
$167.71
+1.68%
USDC
USDC
$1
+0.01%
TRON
TRX
$0.2958
+1.75%
Dogecoin
DOGE
$0.1825
+1.63%
Cardano
ADA
$0.5951
+2.99%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now